Martró E, Domínguez-Hernández R, Forero V, Gómez J, Not A, Manzanares-Laya S, Montoro M, Gómez-Barrera M, Buti M, Casabona J, Majó X, Colom J
Cost-effectiveness of community interventions to promote awareness, testing and treatment of of hepatitis B and C in the migrant population in Catalonia
Jornada Científica CIBERESP. Zaragoza. 28-29 oct 2025
Rodríguez-Lago I, Muñoz Núñez F, Lucendo AJ, De Lossada Juste A, Cabez A, de la Cuadra-Grande A, Oyagüez I, Monte-Boquet E
Cost-effectiveness analysis of etrasimod compared with biologic therapies for patients with moderate-to-severe active ulcerative colitis experienced to previous advanced therapies in Spain
United European Gastroenterology (UEG) Week. Berlin. 4-7 oct 2025
Martró E, Domínguez-Hernández R, Forero V, Gómez J, Not A, Manzanares-Laya S, Montoro M, Gómez-Barrera M, Buti M, Casabona J, Majó X, Colom J
Las intervenciones comunitarias para promover la sensibilización, el diagnóstico y el tratamiento de la hepatitis B y C en la población migrante en Cataluña son coste-efectivas
X Congreso Nacional GEHEP. A Coruña. 25-27 sep 2025
Cebrián-Cuenca AM, Ampudia-Blasco FJ, Bellido-Castañeda V, Carretero-Gómez J, Gómez-Peralta F, Hernández-Martínez AM, Mezquita-Raya P, de la Cuadra-Grande A, Oyagüez I, Robles-Plaza M
FreeStyle Libre glucose monitoring systems in people with T2D on basal insulin: A cost-analysis from the Spanish healthcare system perspective
25th WONCA World Conference. Lisboa. 17-21 sep 2025
Gómez-Peralta F, Robles-Plaza M, Mezquita-Raya P, Hernández AM, Cebrián-Cuenca A, Carretero J, Bellido V, Ampudia-Blasco FJ
Clinical and Economic Value of Flash Glucose Monitoring Systems in the Management of People with Type 2 Diabetes Mellitus on Basal Insulin and Poor Glycemic Control
85th Scientific Sessions – American Diabetes Association (ADA). Chicago. 20-30 jun 2025
Ampudia-Blasco FJ, Oyagüez I, Mezquita-Raya P, Hernández AM, Cebrián-Cuenca A, Carretero J, Bellido V, Gómez-Peralta F
Cost Analysis of FreeStyle Libre® Systems in Patients with Type 2 Diabetes Receiving Basal Insulin and Poor Glycemic Control (HbA1c > 8%): A Societal Perspective in Spain
85th Scientific Sessions – American Diabetes Association (ADA). Chicago. 20-30 jun 2025
Paladio-Duran N, Salinas-Ortega L, de la Cuadra-Grande A, Oyagüez I
Cost-effectiveness analysis of voclosporin vs mycophenolate or belimumab in the treatment of patients with lupus nephritis from the Spanish National Healthcare System perspective
62nd European Renal Association (ERA) Congress. Viena. 4-7 jun 2025
Zaragoza R, Estella A, Nuvials X, Robles M, Casado A
Encuesta nacional a intensivistas sobre el manejo de infecciones fúngicas invasivas (IFI) en pacientes críticamente enfermos
XXVIII Congreso nacional SEIMC (Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica). Málaga. 22-24 may 2025
Cebrián A, Hernández AM, Ampudia-Blasco FJ, Bellido V, Carretero J, Gómez-Peralta F, Mezquita-Raya P